NCT04118426

Brief Summary

This study will assess cognitive function in adult patients with a primary brain tumour treated with surgical resection with or without radiation therapy (RT). All types of brain tumours apart from glioblastoma will be included

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 1, 2018

Completed
1.4 years until next milestone

First Posted

Study publicly available on registry

October 8, 2019

Completed
Last Updated

October 10, 2019

Status Verified

October 1, 2019

Enrollment Period

12 months

First QC Date

June 1, 2018

Last Update Submit

October 7, 2019

Conditions

Keywords

Cognitive function

Outcome Measures

Primary Outcomes (2)

  • Memory impairment (as assessed by the HVLT-r)

    To examine the correlation between memory impairment (assessed by HVLT-r) and mean dose to the hippocampus.

    1-10 years after treatment

  • Neurocognitive function

    Examine correlations cognitive decline and subvolumes of the brain. Cognitive function will be assessed by standardized cognitive tests: Hopkins verbal learning test (HVLT), Trail Making Test part A and B (TMT A and TMT B), Pased Auditory Test (PASAT), Wechsler Adult Intelligence Scale coding and digit span (WAIS-IV), Controlled Oral Word Association Test (Cowat) and STROOP colour and word test (STROOP). Measures on cognitive test is time in seconds or number of "corrects".

    1-10 years after treatment

Secondary Outcomes (5)

  • Global Health - Quality of life

    1-10 years after treatment

  • Fatigue

    1-10 years after treatment

  • Sleep quality

    1-10 years after treatment

  • Depression/Anxiety

    1-10 years after treatment

  • Patients assessment of own cognitive function

    1-10 years after treatment

Study Arms (2)

Radiotherapy group

Patients receiving radiotherapy after surgery for brain tumor

Radiation: Cognitive testing

No radiotherapy group

Patients NOT receiving radiotherapy after surgery for brain tumor

Radiation: Cognitive testing

Interventions

Patients will have their cognitive function tested by the use of standardized cognitive test and fill in questionnaires. Cognitive function will be assessed by standardized cognitive tests: Hopkins verbal learning test (HVLT), Trail Making Test part A and B (TMT A and TMT B), Pased Auditory Test (PASAT), Wechsler Adult Intelligence Scale coding and digit span (WAIS-IV), Controlled Oral Word Association Test (Cowat) and STROOP colour and word test (STROOP) Questionnaire include; Quality of life; EORTC QlQ-C30 (QlQ-C30), FACIT-Fatigue Scale (Version 4) (FACIT), Pittsburg Sleep Quality Index (PSQI), Hospital Anxiety and Depression Scale (HADS), Patient's Assessment of Own Functioning Inventory (PAOFI).

No radiotherapy groupRadiotherapy group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with a primary brain tumour grade I-III

You may qualify if:

  • The participant must be 18 years or older and Danish speaking.
  • Performance status 0-2
  • Capable of cooperating on testing
  • Diagnosed with one of the following diagnoses according to WHO 2016 classification 16 and been treated between 2006 and 2016
  • ZM93803 glioma (exclusive glioblastoma)
  • ZM9401/3 anaplastic astrocytoma, IDH mutant
  • ZM9400/3 diffuse astrocytoma, IDH-mutant
  • ZM9411/3 gemistocytisk astrocytoma, IDH mutant
  • ZM9400/3 diffuse astrocytoma, NOS
  • ZM9451/3 anaplastic oligodendroglioma, IDH mutant and 1p/19q-co deleted
  • ZM9450/3 oligodendroglioma, IDH mutant and 1p/19q-co deleted
  • ZM9450/3 oligodendroglioma, NOS
  • ZM9451/3 anaplastic oligodendroglioma, NOS
  • ZM9530/0 meningioma
  • ZM9470/3 medulloblastoma, NOS
  • +2 more criteria

You may not qualify if:

  • Performance status 3-4 Progression after radiation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aarhus University Hospital

Aarhus, Region Midt, 8000, Denmark

Location

Related Publications (1)

  • Haldbo-Classen L, Amidi A, Lukacova S, Wu LM, Oettingen GV, Lassen-Ramshad Y, Zachariae R, Kallehauge JF, Hoyer M. Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours. Radiother Oncol. 2020 Jul;148:1-7. doi: 10.1016/j.radonc.2020.03.023. Epub 2020 Mar 28.

MeSH Terms

Conditions

Brain NeoplasmsRadiation Injuries

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Officials

  • Morten Høyer, M.D.

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 1, 2018

First Posted

October 8, 2019

Study Start

February 7, 2017

Primary Completion

February 2, 2018

Study Completion

April 12, 2018

Last Updated

October 10, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations